4front Ventures Corp Stock Beta
FFNTF Stock | USD 0.02 0 5.56% |
4Front Ventures Corp fundamentals help investors to digest information that contributes to 4Front Ventures' financial success or failures. It also enables traders to predict the movement of 4Front OTC Stock. The fundamental analysis module provides a way to measure 4Front Ventures' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 4Front Ventures otc stock.
4Front |
4Front Ventures Corp OTC Stock Beta Analysis
4Front Ventures' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current 4Front Ventures Beta | 1.81 |
Most of 4Front Ventures' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 4Front Ventures Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition |
In accordance with the recently published financial statements, 4Front Ventures Corp has a Beta of 1.8077. This is 110.2% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The beta for all United States stocks is notably lower than that of the firm.
4Front Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 4Front Ventures' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of 4Front Ventures could also be used in its relative valuation, which is a method of valuing 4Front Ventures by comparing valuation metrics of similar companies.4Front Ventures is rated # 2 in beta category among its peers.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, 4Front Ventures will likely underperform.
4Front Fundamentals
Return On Equity | -0.74 | |||
Return On Asset | -0.0398 | |||
Profit Margin | (0.32) % | |||
Operating Margin | (0.15) % | |||
Current Valuation | 433.05 M | |||
Shares Outstanding | 640.39 M | |||
Shares Owned By Insiders | 34.18 % | |||
Shares Owned By Institutions | 4.59 % | |||
Price To Book | 5.13 X | |||
Price To Sales | 1.83 X | |||
Revenue | 104.57 M | |||
Gross Profit | 49.4 M | |||
EBITDA | (4.02 M) | |||
Net Income | (38.31 M) | |||
Cash And Equivalents | 6.03 M | |||
Cash Per Share | 0.01 X | |||
Total Debt | 64.62 M | |||
Debt To Equity | 3.72 % | |||
Current Ratio | 0.74 X | |||
Book Value Per Share | 0.08 X | |||
Cash Flow From Operations | 5.78 M | |||
Earnings Per Share | (0.06) X | |||
Target Price | 2.37 | |||
Number Of Employees | 464 | |||
Beta | 1.81 | |||
Market Capitalization | 151.58 M | |||
Total Asset | 255.54 M | |||
Z Score | 1.2 | |||
Net Asset | 255.54 M |
About 4Front Ventures Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 4Front Ventures Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 4Front Ventures using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 4Front Ventures Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in 4Front OTC Stock
4Front Ventures financial ratios help investors to determine whether 4Front OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 4Front with respect to the benefits of owning 4Front Ventures security.